Huawei’s ECG analysis prompt software has obtained the CE medical device certification of the European Union, and the foreign media commented that ＂it is a great improvement of Huawei’s development am

On September 2nd, Huawei ECG App (Huawei ECG Analysis Prompting Software) obtained the CE MDR medical device certification of the European Union, and obtained the pass to enter the markets of the European Union and European Free Trade Area countries. At present, Huawei ECG App has obtained the market access qualification of 33 European countries. In the future, consumers in Europe will be able to use ECG App for single-lead ECG measurement in HUAWEI WATCH GT 3 Pro.

In response to this news, Wareable, a foreign technology website, believes that Huawei, as one of the giants in the smart watch industry, has obtained CE certification for its ECG App, which is a great improvement for Huawei’s development ambition and enables it to compete with Apple and Samsung internationally.

Equipped with high-performance ECG sensor, the heart health guard is upgraded.

Electrocardiogram (ECG) is one of the most commonly used clinical examination methods, and it is also a graphic record of cardiac electrophysiological activities, which hides subtle changes about the heart. In many health problems, ECG monitoring can help users identify irregular heart rhythm, and play a role in reminding early detection, early diagnosis and early treatment. For the ECG monitoring function, as early as 2020, Huawei has launched the first Huawei WATCH GT 2 Pro ECG model that can accurately record ECG data, and then launched the Huawei WATCH GT 3 Pro smart watch equipped with ECG analysis prompt software to support atrial fibrillation and premature beat risk screening.

Huawei WATCH GT 3 Pro ECG signal acquisition technology has been upgraded. The PVD coated electrode on the curved lens of the watch can better fit the skin and improve the quality of ECG signals. Equipped with a high-performance ECG sensor, it works in cooperation with Huawei ECG App. You can collect ECG signals for 30 seconds by touching the side electrode of the watch with your fingertips, and the generated ECG report can be viewed directly at the watch end. After a single measurement, the data can be synchronized to the mobile phone side in real time, and the paid interpretation service of doctors in the top three hospitals in China can be provided to give accurate ECG interpretation results and health care suggestions.

Medical institutions cooperate in depth to protect health in all directions.

Huawei has been deeply involved in the health field for a long time, and has successively launched a series of health management functions and monitoring functions on smart wearable products to help users actively manage their health. Huawei WATCH GT 3 Pro takes TruSeen5.0+ new heart rate monitoring technology as the core, brings a brand-new upgraded multiple health detection system, and cooperates with more professional medical institutions to comprehensively care for users’ health.

Through cooperation with 301 Hospital, Huawei initiated a heart health research project and a sleep apnea research project. Based on WATCH GT 3 Pro high-performance ECG and PPG sensors, it can finely identify heart problems such as atrial fibrillation, premature ventricular beats and premature ventricular beats, and can also intelligently identify information such as sleep, HRV, blood oxygen and heart rate, make multi-parameter fusion judgment, screen the risk of sleep apnea, and provide suggestions for improvement in different levels. In addition, based on various physiological parameters of Huawei WATCH GT 3 Pro, tongji hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology and 301 Hospital jointly launched research in the field of respiratory health to identify the risk of lung infection.

When Huawei WATCH GT 3 Pro was listed in China, Huawei ECG App had already obtained the national second-class medical device certification and achieved good market feedback. This time, Huawei ECG App and HUAWEI WATCH D wrist ECG and blood pressure recorder have obtained CE MDR medical device certification from the European Union, which once again confirms Huawei’s efforts and achievements in the health field. In the future, Huawei will continue to bring more accurate health monitoring functions and provide users with all-round health management.